Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 306 recruiting now early-phase tilt #3 of 28,707 conditions

Obesity: early-phase trial registry

306 of 1,057 indexed Obesity trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3 of 28,707 conditions by registered trial count.

1,057 US clinical trials · 306 currently recruiting · #3 of 28,707 conditions by registered trial count

Obesity: 1,057 US clinical trials tracked, 306 recruiting.

Obesity is the subject of 1,057 registered US clinical trials on ClinicalTrials.gov, 306 of them currently open to new participants. 107 are in Phase 3-4 (later-stage) and 196 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 48 of these trials.

Enrollment posture brief

Registry condition obesity

OPEN 306 | RECR 29% | LATE 107 | EARLY 196 | RANK #3 | SPON 48

Nearest open-share peer: Metastatic Pancreatic Adenocarcinoma (29% recruiting · 38 trials)

Prostate Cancer36.7%Depression35.7%Breast Cancer33.8%Obesity (this)29%Healthy20.5%
Open-enrollment share among volume-matched conditions near Obesity

Obesity lists 306 open slots (29% of 1,057 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Obesity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Obesity is recruiting below its size-band peers.

    306 of 1,057 indexed trials (28.9%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Obesity trials is spread across many organizations.

    Eli Lilly and Company accounts for 48 of 1,057 trials (4.5%). 314 distinct sponsors appear on at least one study for this condition label.

  3. Typical Obesity enrolment sits around 90 participants.

    Median target enrolment is 90 among the 1,054 trials that report a genuine target (sentinel values excluded). 555 of those (52.7%) plan for fewer than 100 participants.

  4. Obesity research is mostly interventional.

    894 interventional and 163 observational studies make up this index (84.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 195Phase 2101Phase 369Phase 438

Open and recent trials

1,057 total, page 17 of 22

COMPLETED NA 60 participants

Effect of Conjugated Linoleic Acid Supplement on Body Composition

University of North Carolina

NCT00347373

COMPLETED NA 60 participants

Feelings About Exercise

The Miriam Hospital

NCT03598647

COMPLETED NA 60 participants

Cognitive Therapy for Binge-Eating Disorder

University of North Carolina, Chapel Hill

NCT00050037

COMPLETED NA 60 participants

Low Fat Vegan or American Heart Association Diets & Cardiovascular Risk in Obese 9-18 y.o. With Elevated Cholesterol

The Cleveland Clinic

NCT01817491

COMPLETED 60 participants

Assessment of Changes in Abdominal Fat

Indiana University

NCT00228579

COMPLETED 60 participants

Adipokines Effect in Myometrial Contractility

University of Minnesota

NCT03505541

COMPLETED NA 60 participants

Diet, Eating, and Lifestyle Improvement for Valued Employees and Their Relatives

University of Pennsylvania

NCT03277040

COMPLETED Phase 4 60 participants

Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity

Weill Medical College of Cornell University

NCT00288873

COMPLETED Phase 4 60 participants

Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids

Mayo Clinic

NCT01733147

COMPLETED NA 59 participants

Progressive Weight Loss and Metabolic Health

Washington University School of Medicine

NCT01299519

COMPLETED Phase 2 59 participants

Insulin Resistance and Reward

VA Office of Research and Development

NCT02241603

COMPLETED NA 58 participants

Fruit and Vegetable Prescription Program

Beth Comerford

NCT04072757

COMPLETED NA 58 participants

Molecular Mechanisms of Exercise Benefits to Insulin Resistant People

Mayo Clinic

NCT04158375

COMPLETED 58 participants

Variability of Physical Assessments in an Older Population That is Overweight or Obese

Versanis Bio

NCT05174923

COMPLETED NA 58 participants

Effect of Resvida, a Comparison With Calorie Restriction Regimen

Washington University School of Medicine

NCT00823381

COMPLETED NA 57 participants

Improving Diabetes Outcomes Through Lifestyle Change (IDOLc)Study

Massachusetts General Hospital

NCT01665989

COMPLETED NA 56 participants

Biologic Effects of Dehydroepiandrosterone (DHEA) in Humans

National Institute on Aging (NIA)

NCT00099697

COMPLETED 56 participants

NT-proBNP Levels and Obesity in Pregnancy

Duke University

NCT04049136

COMPLETED NA 56 participants

The Childhood Health and Asthma Management Program

University of Florida

NCT02303561

COMPLETED NA 55 participants

A Multiple Health Behavior Change Intervention for Overweight and Obese Smokers

Brown University

NCT05136430

COMPLETED 55 participants

Clinical Outcomes, Nutritional Status, Exercise and Psychosocial Factors in Pediatric Hematopoietic Cell Transplant

University of Michigan Rogel Cancer Center

NCT02734797

COMPLETED 54 participants

Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet

Virginia Commonwealth University

NCT03141008

COMPLETED Phase 2 53 participants

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes

GlaxoSmithKline

NCT01725126

COMPLETED NA 53 participants

Varying the Energy Density and Portion Size of the Main Course After a First-course Salad

Penn State University

NCT01729390

COMPLETED NA 53 participants

The Effects of Yoga on Body Image in College Women

University of Delaware

NCT03262350

COMPLETED Phase 2 53 participants

Apnea, Bariatric Surgery Versus Continuous Positive Airway Pressure (CPAP) Trial

University of Pittsburgh

NCT01187771

COMPLETED NA 53 participants

Study of Low Level Laser Therapy to Reduce Body Circumference in Obese Individuals

Erchonia Corporation

NCT01821352

COMPLETED NA 53 participants

Mindfulness Training to Promote Healthy Diet and Physical Activity in Teens

University of Massachusetts, Worcester

NCT01975896

COMPLETED NA 52 participants

Effects of Exercise Training Intensity on Fitness and Insulin Sensitivity in African Americans

East Carolina University

NCT02892331

COMPLETED 52 participants

Seasonal Patterns of Stress, Diet and Physical Activity - Life in All Seasons (LENAS)

USDA Grand Forks Human Nutrition Research Center

NCT01674296

COMPLETED NA 51 participants

Motivational Interviewing for Weight Loss With Young Adults

Virginia Commonwealth University

NCT01899625

COMPLETED NA 51 participants

Ghrelin Regulation and Structure: Effect of Diet Composition on Ghrelin

Oregon Health and Science University

NCT00694512

COMPLETED NA 51 participants

Diet, Imaging and Energy Balance Trial (DIET)

Duke University

NCT00787280

COMPLETED Phase 2 51 participants

Effect of Vitamin D3 Supplementation on Insulin Resistance and Cardiovascular Risk Factors in Obese Adolescents

Mayo Clinic

NCT00858247

COMPLETED NA 50 participants

Effects of Pitavastatin on Insulin Sensitivity and Liver Fat

Massachusetts General Hospital

NCT02290106

COMPLETED NA 50 participants

Rheumatoid Arthritis Coping Enhancement

Duke University

NCT04246827

COMPLETED Phase 1 50 participants

Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT00862433

COMPLETED NA 50 participants

Randomized Trial Comparing Laparoscopic Roux-en-y Gastric Bypass to Micro-laparoscopic Roux-en-y Gastric Bypass

Suzanne J. Rose

NCT01183273

COMPLETED NA 50 participants

Gender- and Culturally-Sensitive Weight Loss Intervention for Hispanic Males

University of Arizona

NCT02783521

COMPLETED 50 participants

Effect of Obesity on Immune Response to Pneumovax 23

University of Florida

NCT02471014

COMPLETED Phase 1 50 participants

Multiple Ascending Dose Study of AMG 598 in Adults With Obesity

Amgen

NCT03757130

COMPLETED 50 participants

Functional MRI of Stress in Obesity

Yale University

NCT01719484

COMPLETED NA 50 participants

MPOWERed Messages: Tailored Mobile Messages to Enhance Weight Loss for Teens

University of Michigan

NCT01448551

COMPLETED NA 50 participants

Pilot Behavioral Support Intervention After Bariatric Surgery

Geisinger Clinic

NCT03092479

COMPLETED Phase 2 50 participants

A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene

Repros Therapeutics

NCT02651688

COMPLETED NA 49 participants

Exercise as a Buffer Against Stress-induced Overeating

The Miriam Hospital

NCT02936076

COMPLETED Phase 2 49 participants

Oxidative Stress in Asthma

Bastiaan Driehuys

NCT04512547

COMPLETED 48 participants

Bariatric Surgery and Weight Loss on Energy Metabolism and Insulin Sensitivity

Pennington Biomedical Research Center

NCT00936130

COMPLETED NA 48 participants

Regulation of Muscle Protein Phenotype in Humans With Obesity

Mayo Clinic

NCT04700800

COMPLETED NA 48 participants

Eating Mindfully to Prevent Weight Regain

University of Utah

NCT04847843

← Previous Page 17 of 22 Next →

Phase Distribution

PhaseTrial count
Phase 1 95
Phase 2 101
Phase 3 69
Phase 4 38

Named interventions

Most-linked intervention names on Obesity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
108 trials
Tirzepatide Drug
30 trials
Semaglutide Drug
20 trials
Placebo Other
18 trials
Liraglutide Drug
10 trials
Exercise Behavioral
10 trials
Placebo Dietary supplement
10 trials
Orforglipron Drug
9 trials

US sites by state

Facility locations filed on Obesity trials. A trial with sites in several states counts in each.

California 197 trials
Florida 132 trials
Texas 95 trials
North Carolina 93 trials
New York 91 trials
Pennsylvania 86 trials
Massachusetts 80 trials
Illinois 73 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Obesity page

1,057 registered trials, 306 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Obesity condition card totals 1,057 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.